[1]张帅,倪才方,朱晓黎,等.经皮穿刺纳米刀消融治疗恶性肿瘤的初步应用（附3例报道）[J].介入放射学杂志,2016,(07):606-609.
　ZHANG Shuai,NI Cai-fang,ZHU Xiao-li,et al.Percutaneous NanoKnife ablation for the treatment of malignant tumors: preliminary results with report of three cases [J].journal interventional radiology,2016,(07):606-609.
点击复制

经皮穿刺纳米刀消融治疗恶性肿瘤的初步应用（附3例报道） ()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2016年07期
页码:
606-609
栏目:
非血管介入
出版日期:
2016-07-25

文章信息/Info

Title:
Percutaneous NanoKnife ablation for the treatment of malignant tumors: preliminary results with report of three cases

作者:
张帅; 倪才方; 朱晓黎; 王万胜; 李智; 李婉慈; 陈涛
Author(s):
ZHANG Shuai;  NI Cai-fang;  ZHU Xiao-li;  WANG Wan-sheng;  LI Zhi;  LI Wan-ci;  CHEN Tao
Department of Interventional Radiology, First Affiliated Hospital of Suzhou University, Suzhou, Jiangsu Province 215006, China
关键词:
【关键词】纳米刀;  恶性肿瘤;  临床应用
文献标志码:
A
摘要:
【摘要】目的探讨经皮穿刺纳米刀消融技术治疗恶性肿瘤的的初步临床应用。方法1例肝恶性肿瘤、2例胰腺恶性肿瘤患者在全麻下分别接受经皮穿刺纳米刀消融术，并以实体瘤疗效评价标准（RECIST1.1）进行疗效评价。结果3例患者术中、术后均无明显并发症发生，术后2个月复查，1例患者肿瘤完全失活，达到完全缓解，另2例肿瘤大部分坏死、但周围仍有部分活性，其中1例还出现远处转移，分别达到部分缓解和疾病进展。结论纳米刀消融术安全、有效，与传统消融手段相比优势独到，应用前景广泛，但在其临床应用中应注意严格把握适应证，并注重与其他治疗方法的联合应用。


参考文献/References:

［1］He J, Page AJ, Weiss M, et al. Management of borderline and locally advanced pancreatic cancer: where do we stand?［J］. World J Gastroenterol, 2014, 20: 2255-2266.

［2］Keane MG, Bramis K, Pereira SP, et al. Systematic review of novel ablative methods in locally advanced pancreatic cancer［J］. World J Gastroenterol, 2014, 20: 2267-2278.

［3］Ball C, Thomson KR, Kavnoudias H. Irreversible electroporation: a new challenge in “out of operating theater” anesthesia［J］. Anesth Analg, 2010, 110: 1305-1309.

［4］Fanta J, Horak P, Marvan J, et al. The NanoKnife and two successful cases of intracavitary irreversible electroporation of main bronchus tumours［J］. Rozhl Chir, 2012, 91: 625-630.

［5］Wendler JJ, Pech M, Porsch M, et al. Urinary tract effects after multifocal nonthermal irreversible electroporation of the kidney: acute and chronic monitoring by magnetic resonance imaging, intravenous urography and urinary cytology［J］. Cardiovasc Intervent Radiol, 2012, 35: 921-926.

［6］Neal RE 2nd， Garcia PA， Robertson JL， et a1. Experimental characterization of intrapulse tissue conductivity changes for electroporation［J］. Conf Proc IEEE Eng Med Biol Soc, 2011, 2011： 5581-5584.

［7］Long G, Bakos G, Shires PK, et al. Histological and finite element analysis of cell death due to irreversible electroporation［J］. Technol Cancer Res Treat, 2013, 13: 561-569.

［8］Narayanan G, Froud T, Lo K, et al. Pain analysis in patients with hepatocellular carcinoma: irreversible electroporation versus radiofrequency ablation-initial observations［J］. Cardiovasc Intervent Radiol, 2013, 36: 176-182.

［9］宋飞虹， 陈永亮， 苏明， 等. 纳米刀消融胰腺组织的动物实验［J］. 中华肝胆外科杂志， 2015， 21： 328-331.

［10］Martin RC 2nd, McFarland K, Ellis S, et al. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival［J］. Ann Surg Oncol, 2013, 20: S443-S449.

［11］Martin RC 2nd, McFarland K, Ellis S, et al. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma［J］. J Am Coll Surg, 2012, 215: 361-369.

［12］Thomson KR, Cheung W, Ellis SJ, et al. Investigation of the safety of irreversible electroporation in humans［J］. J Vasc Interv Radiol, 2011, 22: 611-621.

［13］牛立志， 曾健滢， 张志凯， 等. 纳米刀治疗胰腺癌现状［J］. 中华胰腺病杂志， 2014， 14： 420-423.

［14］Kingham TP, Karkar AM, Dangelica MI, et al. Ablation of perivascular hepatic malignant tumors with irreversible electroporation［J］. J Am Coll Surg, 2012, 215: 379-387.

［15］Faroja M, Ahmed M, Appelbaum L, et al. Irreversible electroporation ablation: is all the damage nonthermal?［J］. Radiology, 2013, 266: 462-470.

［16］何晓锋， 肖越勇. 纳米刀肿瘤消融治疗的临床应用进展［J］. 中华放射学杂志， 2014， 48： 878-880.

［17］孙钢. 不可逆电穿孔技术消融肿瘤研究进展［J］. 介入放射学杂志， 2015， 24： 277-281.

［18］Cheung W, Kavnoudias H, Roberts S, et al. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes［J］. Technol Cancer Res Treat, 2013, 12: 233-241.

［19］Cannon R, Ellis S, Hayes D, et al. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures［J］. J Surg Oncol, 2013, 107: 544-549.

［20］Kluger MD, Epelboym I, Schrope BA, et al. Single-institution experience with irreversible electroporation for T4 pancreatic cancer: first 50 patients.［J］ Ann Surg Oncol， 2016, 23: 1736-1743.

［21］Charpentier KP. Irreversible electroporation for the ablation of liver tumors: are we there yet?［J］. Arch Surg, 2012, 147: 1053-1061.

［22］中华医学会外科学分会胰腺外科学组. 胰腺癌诊治指南（2014）［J］. 中华普通外科学文献·电子版， 2014， 20： 424-431.

 

相似文献/References:

[1]何乾文,何远忠,罗来华,等.自制简易碘油推送器[J].介入放射学杂志,2000,(03):134.
[2]昝露霞,刘树惠,程永德,等.介入病房护理工作的体会[J].介入放射学杂志,1997,(01):51.
[3]吉美玲.肾癌介入治疗及护理[J].介入放射学杂志,1997,(04):236.
[4]余建军.直肠癌手术前介入治疗三例[J].介入放射学杂志,1998,(02):102.
[5]韩旭,杨家政,左庆云,等.选择性肝动脉灌注化疗及栓塞治疗原发性巨块型肝癌[J].介入放射学杂志,1998,(03):171.
[6]黄小明,于淼,暴军玲,等.甲氧氯普胺治疗肝癌介入治疗中的胃肠道反应[J].介入放射学杂志,1998,(04):245.
[7]邓力,陈庆强,卢秋红.华蟾素配合介入治疗原发性肝癌临床观察[J].介入放射学杂志,1999,(01):43.
[8]詹迎江,虞喜豪,张正国,等.保尔佳与介入治疗恶性肿瘤联合应用的初步体会[J].介入放射学杂志,1994,(02):109.
[9]萧湘生.肺癌介入治疗若干问题探讨[J].介入放射学杂志,1994,(03):125.
[10]许秀芳,程永德,丁美娟,等.肺癌介入治疗后的护理[J].介入放射学杂志,1994,(04):232.

备注/Memo

备注/Memo:
(收稿日期：2016-01-18）


(本文编辑：俞瑞纲）
更新日期/Last Update: 2016-07-18